Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 01, 2023

SELL
$229.71 - $259.35 $1.29 Million - $1.45 Million
-5,600 Reduced 91.8%
500 $0
Q4 2022

Feb 07, 2023

BUY
$218.29 - $256.91 $1.27 Million - $1.49 Million
5,800 Added 1933.33%
6,100 $74,000
Q3 2022

Oct 25, 2022

BUY
$51.03 - $264.23 $15,309 - $79,269
300 New
300 $0
Q2 2018

Aug 10, 2018

SELL
$208.1 - $233.85 $520,250 - $584,625
-2,500 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$205.46 - $240.27 $2.14 Million - $2.5 Million
-10,400 Reduced 80.62%
2,500 $19,000
Q4 2017

Jan 17, 2018

SELL
$189.0 - $222.64 $2.76 Million - $3.25 Million
-14,600 Reduced 53.09%
12,900 $183,000
Q3 2017

Oct 17, 2017

BUY
$186.89 - $198.9 $5.14 Million - $5.47 Million
27,500
27,500 $149,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.